A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer.

Dong YangYanbin ZhangPing GongFeiran LiuYale GanWen-Pei Bai

Published in: The journal of obstetrics and gynaecology research (2023)

This study suggested that SeCRS plus HIPEC followed by chemotherapy resulted in longer overall survival and PFS than only SeCRS followed by chemotherapy in patients with recurrent ovarian cancer, especially in patients who were treated with repeat HIPEC.

Keyphrases

locally advanced
minimally invasive
coronary artery bypass
squamous cell carcinoma
chemotherapy induced
percutaneous coronary intervention
acute coronary syndrome
atrial fibrillation